Corporate Investigations

Investigative coverage of business risks and opportunities

Our corporate investigations coverage identifies companies and industries that may be impacted by new or existing laws and regulations. For individual companies, we report on specific business practices that may pose legal or regulatory risks. Our industry-focused content examines new regulations that may materially affect an entire industry, as well as identifying the companies within the industry likely to be most impacted. Our journalists understand the impact regulatory agency actions can have on financial markets and provide insights on the potential results of regulatory actions, whether they include fines or material changes to a company’s business or an industry’s operation.

PDF

RECENT Corporate Investigations COVERAGE

View all

Encompass Health: Facilities Across the Country Misusing Neurological Diagnosis to Increase Medicare Payments; Conduct Echoes Those Highlighted in 2019 DOJ Settlement

In 2019, Encompass Health (EHC), the country’s largest operator of inpatient rehabilitation facilities (IRF), entered into a settlement with the Department of Justice for $48 million to resolve allegations that its hospitals falsely diagnosed patients to increase Medicare payments and...

Jul 25, 2025 Read Now >
Novo Nordisk: Company Did Not Report or Investigate Deaths Potentially Caused by Ozempic

Novo Nordisk (NVO) did not report multiple deaths that may have been caused by its blockbuster weight loss drug Ozempic to the FDA, according to an agency inspection report obtained by The Capitol Forum through a Freedom of Information Act request… The rest of this article is...

Jul 15, 2025 Read Now >
Prestige Consumer Healthcare: Subsidiary Kept Mold-Contaminated Enemas on Market and Declined to Investigate Source of Outbreak, According to FDA Inspection

Between 2023 and 2025, Fleet, a subsidiary of Prestige Consumer Healthcare (PBH) that manufactures enemas and suppositories, received several complaints that its adult and pediatric enemas were being shipped to customers with visible signs of mold. Despite these complaints, however, the...

Jul 11, 2025 Read Now >

What our Customers Say

Barry Nigro

Partner and Antitrust Chair, Fried Frank

"The Capitol Forum’s articles include a good mix of investigative journalism combined with expert analysis and opinion."
Katrina Robson

Partner, Willkie Farr & Gallagher

"Capitol Forum’s comprehensive and diligent reporting on key competitive issues provides helpful insights on and contributes to the vigorous debate around antitrust policy and enforcement."
Mark Ostrau

Partner, Fenwick & West

"I rely on Capitol Forum daily for its valuable combination of timely information and unique insights on key deals and cases. It offers viewpoints and analyses that others don’t, which has become particularly valuable in the current policy environment."
Kevin Hahm

Partner, Hunton Andrews Kurth

"I rely on Capitol Forum to get insight and analysis that’s often unavailable from other sources. Their coverage of FTC and DOJ matters is top-notch."